186 related articles for article (PubMed ID: 12154404)
1. The study of aberrant methylation in cancer via restriction landmark genomic scanning.
Smiraglia DJ; Plass C
Oncogene; 2002 Aug; 21(35):5414-26. PubMed ID: 12154404
[TBL] [Abstract][Full Text] [Related]
2. Restriction landmark genomic scanning: analysis of CpG islands in genomes by 2D gel electrophoresis.
Costello JF; Hong C; Plass C; Smiraglia DJ
Methods Mol Biol; 2009; 507():131-48. PubMed ID: 18987812
[TBL] [Abstract][Full Text] [Related]
3. Integrated genomic and epigenomic analyses pinpoint biallelic gene inactivation in tumors.
Zardo G; Tiirikainen MI; Hong C; Misra A; Feuerstein BG; Volik S; Collins CC; Lamborn KR; Bollen A; Pinkel D; Albertson DG; Costello JF
Nat Genet; 2002 Nov; 32(3):453-8. PubMed ID: 12355068
[TBL] [Abstract][Full Text] [Related]
4. A NotI-EcoRV promoter library for studies of genetic and epigenetic alterations in mouse models of human malignancies.
Yu L; Liu C; Bennett K; Wu YZ; Dai Z; Vandeusen J; Opavsky R; Raval A; Trikha P; Rodriguez B; Becknell B; Mao C; Lee S; Davuluri RV; Leone G; Van den Veyver IB; Caligiuri MA; Plass C
Genomics; 2004 Oct; 84(4):647-60. PubMed ID: 15475242
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia.
Gebhard C; Schwarzfischer L; Pham TH; Schilling E; Klug M; Andreesen R; Rehli M
Cancer Res; 2006 Jun; 66(12):6118-28. PubMed ID: 16778185
[TBL] [Abstract][Full Text] [Related]
6. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future.
Esteller M
Oncogene; 2002 Aug; 21(35):5427-40. PubMed ID: 12154405
[TBL] [Abstract][Full Text] [Related]
7. An AscI boundary library for the studies of genetic and epigenetic alterations in CpG islands.
Dai Z; Weichenhan D; Wu YZ; Hall JL; Rush LJ; Smith LT; Raval A; Yu L; Kroll D; Muehlisch J; Frühwald MC; de Jong P; Catanese J; Davuluri RV; Smiraglia DJ; Plass C
Genome Res; 2002 Oct; 12(10):1591-8. PubMed ID: 12368252
[TBL] [Abstract][Full Text] [Related]
8. Cell type-specific methylation profiles occurring disproportionately in CpG-less regions that delineate developmental similarity.
Sakamoto H; Suzuki M; Abe T; Hosoyama T; Himeno E; Tanaka S; Greally JM; Hattori N; Yagi S; Shiota K
Genes Cells; 2007 Oct; 12(10):1123-32. PubMed ID: 17903172
[TBL] [Abstract][Full Text] [Related]
9. Restriction landmark genomic scanning for DNA methylation in cancer: past, present, and future applications.
Rush LJ; Plass C
Anal Biochem; 2002 Aug; 307(2):191-201. PubMed ID: 12202234
[TBL] [Abstract][Full Text] [Related]
10. Restriction landmark genomic scanning (RLGS-M)-based genome-wide scanning of mouse liver tumors for alterations in DNA methylation status.
Akama TO; Okazaki Y; Ito M; Okuizumi H; Konno H; Muramatsu M; Plass C; Held WA; Hayashizaki Y
Cancer Res; 1997 Aug; 57(15):3294-9. PubMed ID: 9242463
[TBL] [Abstract][Full Text] [Related]
11. Gene silencing by DNA methylation in haematological malignancies.
Boultwood J; Wainscoat JS
Br J Haematol; 2007 Jul; 138(1):3-11. PubMed ID: 17489980
[TBL] [Abstract][Full Text] [Related]
12. A new class of tissue-specifically methylated regions involving entire CpG islands in the mouse.
Suzuki M; Sato S; Arai Y; Shinohara T; Tanaka S; Greally JM; Hattori N; Shiota K
Genes Cells; 2007 Dec; 12(12):1305-14. PubMed ID: 18076568
[TBL] [Abstract][Full Text] [Related]
13. Restriction landmark genome scanning.
Costello JF; Smiraglia DJ; Plass C
Methods; 2002 Jun; 27(2):144-9. PubMed ID: 12095273
[TBL] [Abstract][Full Text] [Related]
14. Aberrant hypermethylation of the major breakpoint cluster region in 17p11.2 in medulloblastomas but not supratentorial PNETs.
Frühwald MC; O'Dorisio MS; Dai Z; Rush LJ; Krahe R; Smiraglia DJ; Pietsch T; Elsea SH; Plass C
Genes Chromosomes Cancer; 2001 Jan; 30(1):38-47. PubMed ID: 11107174
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide and locus-specific DNA hypomethylation in G9a deficient mouse embryonic stem cells.
Ikegami K; Iwatani M; Suzuki M; Tachibana M; Shinkai Y; Tanaka S; Greally JM; Yagi S; Hattori N; Shiota K
Genes Cells; 2007 Jan; 12(1):1-11. PubMed ID: 17212651
[TBL] [Abstract][Full Text] [Related]
16. Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features.
Cho NY; Kim BH; Choi M; Yoo EJ; Moon KC; Cho YM; Kim D; Kang GH
J Pathol; 2007 Feb; 211(3):269-77. PubMed ID: 17139617
[TBL] [Abstract][Full Text] [Related]
17. DNA hypermethylation: when tumour suppressor genes go silent.
Garinis GA; Patrinos GP; Spanakis NE; Menounos PG
Hum Genet; 2002 Aug; 111(2):115-27. PubMed ID: 12189484
[TBL] [Abstract][Full Text] [Related]
18. A new tool for the rapid cloning of amplified and hypermethylated human DNA sequences from restriction landmark genome scanning gels.
Smiraglia DJ; Frühwald MC; Costello JF; McCormick SP; Dai Z; Peltomäki P; O'Dorisio MS; Cavenee WK; Plass C
Genomics; 1999 Jun; 58(3):254-62. PubMed ID: 10373323
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation in cancer: too much, but also too little.
Ehrlich M
Oncogene; 2002 Aug; 21(35):5400-13. PubMed ID: 12154403
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation, imprinting and cancer.
Plass C; Soloway PD
Eur J Hum Genet; 2002 Jan; 10(1):6-16. PubMed ID: 11896451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
